| Aim:To observe clinical curative effect of Fu, s Subcutaneous Needling therapy treating the Third Lumbar Transverse Process Syndrome, and provide a long-term, stable and effective clinical treatment for it.Methods:80 patients conformed to the standard were randomly divided into two groups, Fu’ s Subcutaneous Needling group (treatment group), the Tuina group (control group),40 cases in each group. Treatment group with Fu’ s Subcutaneous Needling therapy, in dwelling floating soft tube under the skin, taking out the third day and this is a period of treatment, and four days rest between each period. The control group uses theTuina therapy, 1 times a day, every time 30 minutes, five times for a period of treatment, and 2 days off after each period. Both groups are of four periods of treatment. observe the patient’s subjective symptoms and signs as well as the ability of daily life (ADL), uses the JOA score scale, VAS pain scale score, and calculate the JOA scores, improvement tatio, and analyze the data, before and one month and half a year after the treatment.Results:1. JOA results showed that the treatment group 40 cases,3 cases of recovery,28 cases were markedly effective, effective 7 cases, ineffective in 2 cases, total effective rate 95%, markedly effective rate was 70%; Control group 40 cases,1 case was cured,18 cases were markedly effective, effective 18 cases,3 had no effect, the total effective rate 92.5%, markedly effective rate was 45%. Compared by the rank and inspection, treatment group was significantly better than the control group (P< 0.01).2. Subjective symptoms, signs, ADL JOA score and total score results showed:before the treatment, two groups of score have no statistical difference (P> 0.05), are comparable. Group comparison:compared with before treatment, the treatment group and control group in one month after treatment, six months later the review score were higher (P< 0.05); Compared with one month after treatment, the treatment group after six months review score has no statistical difference (P> 0.05), and the control group (P< 0.05). Comparison between groups:compared with control group, treatment group after treatment for a month, half a year after the review score were higher (P< 0.05).3. VAS score results showed that before the treatment, two groups of score have no statistical difference (P> 0.05), and are comparable. Group comparison:compared with treatment before, the treatment group and control group in one month after treatment, six months after review scores were lower (P< 0.05); Compared with one month after the treatment, the treatment group after six months review score has no statistical difference (P> 0.05), and the control group (P< 0.05). Comparison between groups:compared with control group, treatment group after treatment for a month, half a year the review scores were lower (P< 0.05).Conclusion:1. Fu’ s Subcutaneous Needling therapy and Tuina can obviously improve the third lumbar transverse process syndrome patients of subjective symptoms, signs, daily life ability, improve the patients quality of life.2. Compared with the Tuina therapy, Fu’ s Subcutaneous Needling therapy treating the third lumbar transverse process syndrome,the clinical curative effect is better, the long-term curative effect is stable, and is worthy of clinical promotion and application. |